Serum amyloid P component binds to Fcγ receptors and opsonizes particles for phagocytosis

被引:130
作者
Bharadwaj, D
Mold, C
Markham, E
Du Clos, TW
机构
[1] Vet Affairs Med Ctr, Res Serv 151, Albuquerque, NM 87108 USA
[2] Univ New Mexico, Sch Med, Dept Med, Albuquerque, NM 87108 USA
[3] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87108 USA
关键词
D O I
10.4049/jimmunol.166.11.6735
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serum amyloid P component (SAP) is a member of the pentraxin family of proteins. These proteins are characterized by cyclic pentameric structure, calcium-dependent ligand binding, and frequent regulation as acute-phase serum proteins. SAP is the serum precursor of the P component of amyloid. It binds to a broad group of molecules, including autoantigens, through a pattern recognition binding site. The related pentraxin, C-reactive protein (CRP), is a strong acute-phase reactant in man and an opsonin. We previously determined that the binding of CRP to leukocytes occurs through Fe receptors for IgG (Fc gammaR). We now report that SAP also binds to Fc gammaR and opsonizes particles for phagocytosis by human polymorphonucIear leukocytes (PMN). Specific, saturable binding of SAP to FcRI, FcRIIa, and Fc gamma RIIIb expressed on transfected COS cells was detected using SAP-biotin and PE-streptavidin. Zymosan was used to test the functional consequences of SAP and CRP binding to Fc gammaR. Both SAP and CRP bound to zymosan and enhanced its uptake by PMN. This enhanced phagocytosis was abrogated by treatment of PMN with wortmannin, a phosphatidylinositol-3 kinase inhibitor, or with piceatannol, a Syk inhibitor, consistent with uptake through FcR. Treatment of PMN with phosphatidylinositol-specific phospholipase C to remove Fc gamma RIIIb also decreased phagocytosis of SAP-opsonized zymosan, but not CRP-opsonized zymosan. These results suggest that SAP may function in host defense. In addition, as SAP binds to chromatin, a major immunogen in systemic lupus erythematosus, it may provide a clearance mechanism for this Ag through Fc gammaR bearing cells. The Journal of Immunology, 2001.
引用
收藏
页码:6735 / 6741
页数:7
相关论文
共 39 条
  • [1] WORTMANNIN IS A POTENT PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR - THE ROLE OF PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE IN NEUTROPHIL RESPONSES
    ARCARO, A
    WYMANN, MP
    [J]. BIOCHEMICAL JOURNAL, 1993, 296 : 297 - 301
  • [2] The major receptor for C-reactive protein on leukocytes is Fcγ receptor II
    Bharadwaj, D
    Stein, MP
    Volzer, M
    Mold, C
    Du Clos, TW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (04) : 585 - 590
  • [3] Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity
    Bickerstaff, MCM
    Botto, M
    Hutchinson, WL
    Herbert, J
    Tennent, GA
    Bybee, A
    Mitchell, DA
    Cook, HT
    Butler, PJG
    Walport, MJ
    Pepys, MB
    [J]. NATURE MEDICINE, 1999, 5 (06) : 694 - 697
  • [4] Burlingame RW, 1996, J IMMUNOL, V156, P4783
  • [5] PENTRAXIN-CHROMATIN INTERACTIONS - SERUM AMYLOID-P COMPONENT SPECIFICALLY DISPLACES H1-TYPE HISTONES AND SOLUBILIZES NATIVE LONG CHROMATIN
    BUTLER, PJG
    TENNENT, GA
    PEPYS, MB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (01) : 13 - 18
  • [6] CROWELL RE, 1991, J IMMUNOL, V147, P3445
  • [7] A critical role for Syk in signal transduction and phagocytosis mediated by Fc gamma receptors on macrophages
    Crowley, MT
    Costello, PS
    FitzerAttas, CJ
    Turner, M
    Meng, FY
    Lowell, C
    Tybulewicz, VLJ
    DeFranco, AL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) : 1027 - 1039
  • [8] DELEAN A, 1982, MOL PHARMACOL, V21, P5
  • [9] Function of C-reactive protein
    Du Clos, TW
    [J]. ANNALS OF MEDICINE, 2000, 32 (04) : 274 - 278
  • [10] The interaction of C-reactive protein and serum amyloid P component with nuclear antigens
    DuClos, TW
    [J]. MOLECULAR BIOLOGY REPORTS, 1996, 23 (3-4) : 253 - 260